Centre de Recherche en Infectiologie Porcine, Faculté de Médecine Vétérinaire, Université de Montréal , St-Hyacinthe, Québec, Canada.
Microb Drug Resist. 2012 Apr;18(2):198-206. doi: 10.1089/mdr.2011.0150. Epub 2011 Dec 28.
Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia, a severe and highly contagious respiratory disease responsible for economic losses in the swine industry worldwide. Although antimicrobial resistance in A. pleuropneumoniae has been recently reported in different countries, the current situation in Canada is unknown. The aim of the current study was to determine the antimicrobial susceptibilities of 43 strains of A. pleuropneumoniae isolated in Canada. In addition, antimicrobial resistance genes were detected with an oligonucleotide microarray. The impact of biofilm formation on susceptibility to antimicrobials was also evaluated. All isolates were susceptible to ceftiofur, florfenicol, enrofloxacin, erythromycin, clindamycin, trimethoprim/sulfamethoxazole, and tilmicosin. A low level of resistance was observed toward tiamulin, penicillin, and ampicillin as well as danofloxacin. We observed a high level of resistance to chlortetracycline (88.4%) and oxytetracycline (90.7%). The strains showing resistance to tetracycline antimicrobials contained at least one of the following tet genes: tetB, tetO, tetH, or tetC. Five isolates showed multiresistance to penicillins (bla(ROB-1)), streptomycin [aph3'' (strA)], sulfonamides (sulII), and tetracyclines (tetO) antimicrobials whereas three others showed multiresistance to streptomycin [aph3'' (strA)], sulfonamides (sulII), and tetracyclines (tetB, tetO, or tetB/tetH) antimicrobials. To the best of our knowledge, this is the first description of tetC gene in Pasteurellaceae. Finally, cells of A. pleuropneumoniae in a biofilm were 100 to 30,000 times more resistant to antimicrobials than their planktonic counterparts.
胸膜肺炎放线杆菌是猪传染性胸膜肺炎的病原体,这种严重且高度传染性的呼吸道疾病在全球范围内给养猪业造成了经济损失。尽管最近在不同国家报道了胸膜肺炎放线杆菌对抗菌药物的耐药性,但加拿大目前的情况尚不清楚。本研究的目的是确定在加拿大分离的 43 株胸膜肺炎放线杆菌对抗菌药物的敏感性。此外,还使用寡核苷酸微阵列检测了抗菌药物耐药基因。还评估了生物膜形成对抗菌药物敏感性的影响。所有分离株均对头孢噻呋、氟苯尼考、恩诺沙星、红霉素、克林霉素、复方磺胺甲噁唑和替米考星敏感。对泰妙菌素、青霉素和氨苄西林以及达氟沙星的耐药率较低。我们观察到对金霉素(88.4%)和土霉素(90.7%)的耐药率较高。对四环素类抗菌药物耐药的菌株至少含有以下 tet 基因之一:tetB、tetO、tetH 或 tetC。5 株分离株对青霉素(bla(ROB-1))、链霉素[aph3''(strA)]、磺胺类药物(sulII)和四环素类(tetO)抗菌药物表现出多药耐药性,而另外 3 株分离株对链霉素[aph3''(strA)]、磺胺类药物(sulII)和四环素类(tetB、tetO 或 tetB/tetH)抗菌药物表现出多药耐药性。据我们所知,这是首次在巴斯德氏菌科中描述 tetC 基因。最后,生物膜中的胸膜肺炎放线杆菌细胞对抗菌药物的耐药性比浮游细胞高 100 至 30,000 倍。